Literature DB >> 17406171

Predictors of bipolar disorder risk among patients currently treated for major depression.

Joseph R Calabrese1, David J Muzina, David E Kemp, Gary S Sachs, Mark A Frye, Thomas R Thompson, David Klingman, Michael L Reed, Robert M A Hirschfeld.   

Abstract

OBJECTIVE: The primary objective of this study was to assess the rate of bipolar disorder (BPD) risk among patients unsuccessfully treated for major depression and to identify predictors of bipolarity. PATIENTS, DESIGN, AND
SETTING: Psychiatrists from community and private practice settings sequentially selected patients with unipolar depression who exhibited nonresponse to at least 1 antidepressant (AD) trial. MAIN OUTCOME MEASURES: Patients self-reported their demographics, family history, comorbid health status, and legal problems. Current depression symptoms were assessed via the Centers for Epidemiologic Studies--Depression (CES-D) scale. Bipolar screening was performed using the Mood Disorder Questionnaire (MDQ). A psychiatrist recorded patient history and current and prior AD medication use.
RESULTS: Of 602 patients enrolled, 18.6% screened positive on the MDQ. This rate was not affected by the number of prior AD failures or patient demographics. A prior history of BPD was reported by 12.3% of patients of which the psychiatrist was not aware or did not report, and 41.2% of these patients were MDQ+. Stepwise logistic regression identified 5 variables associated with bipolar disorder risk: the CES-D item "people were unfriendly," comorbid anxiety, initial depression diagnosis within 5 years, family history of BPD, and legal problems. In the subset of patients with complete data for the 5 variables (n = 483), 41.3% of the patients endorsing any 3 or more risk factors (n = 109) were MDQ+.
CONCLUSIONS: Almost 20% of patients with AD nonresponsive unipolar depression screened positive for BPD and the number of past medication trials had no effect on bipolarity. This suggests that clinicians should carefully screen for BPD in patients who have failed at least 1 antidepressant. Comorbid anxiety, feelings of people being unfriendly, recent depression diagnosis, BPD family history, and legal problems may prove useful indicators of BPD risk among patients who have failed at least 1 antidepressant. Future studies are needed to confirm that these risk factors are useful clinical variables to screen for bipolarity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406171      PMCID: PMC1781328     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  39 in total

1.  Validity of the mood disorder questionnaire: a general population study.

Authors:  Robert M A Hirschfeld; Charles Holzer; Joseph R Calabrese; Myrna Weissman; Michael Reed; Marilyn Davies; Mark A Frye; Paul Keck; Susan McElroy; Lydia Lewis; Jonathan Tierce; Karen D Wagner; Elizabeth Hazard
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

Review 2.  Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression.

Authors:  Joseph F Goldberg; S Nassir Ghaemi
Journal:  Bipolar Disord       Date:  2005       Impact factor: 6.744

3.  Screening for bipolar disorder in a primary care practice.

Authors:  Amar K Das; Mark Olfson; Marc J Gameroff; Daniel J Pilowsky; Carlos Blanco; Adriana Feder; Raz Gross; Yuval Neria; Rafael Lantigua; Steven Shea; Myrna M Weissman
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

4.  Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice.

Authors:  F Benazzi
Journal:  J Affect Disord       Date:  1997-04       Impact factor: 4.839

5.  Impact of bipolar disorder on a U.S. community sample.

Authors:  Joseph R Calabrese; Robert M A Hirschfeld; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen D Wagner
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

6.  [Hypomania. Apropos of a cohort of young patients].

Authors:  J Angst
Journal:  Encephale       Date:  1992-01       Impact factor: 1.291

Review 7.  Definition and epidemiology of treatment-resistant depression.

Authors:  M Fava; K G Davidson
Journal:  Psychiatr Clin North Am       Date:  1996-06

8.  Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort.

Authors:  N Kennedy; R Abbott; E S Paykel
Journal:  Psychol Med       Date:  2003-07       Impact factor: 7.723

9.  Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien; K A Druley
Journal:  Arch Gen Psychiatry       Date:  1983-06

10.  Treatment and response in refractory depression: results from a specialist affective disorders service.

Authors:  N Kennedy; E S Paykel
Journal:  J Affect Disord       Date:  2004-07       Impact factor: 4.839

View more
  11 in total

Review 1.  An overview of mood disorders in the DSM-5.

Authors:  Jan Fawcett
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

2.  Prevalence of Bipolar Disorder symptoms in Primary Care (ProBiD-PC): A Canadian study.

Authors:  John F Chiu; Pratap R Chokka
Journal:  Can Fam Physician       Date:  2011-02       Impact factor: 3.275

Review 3.  A comprehensive review and model of putative prodromal features of bipolar affective disorder.

Authors:  O D Howes; S Lim; G Theologos; A R Yung; G M Goodwin; P McGuire
Journal:  Psychol Med       Date:  2010-09-14       Impact factor: 7.723

Review 4.  Subthreshold bipolarity: diagnostic issues and challenges.

Authors:  Robin Nusslock; Ellen Frank
Journal:  Bipolar Disord       Date:  2011 Nov-Dec       Impact factor: 6.744

5.  Measuring Intrusive Prospective Imagery using the Impact of Future Events Scale (IFES): Psychometric properties and relation to risk for Bipolar Disorder.

Authors:  Catherine Deeprose; Aiysha Malik; Emily A Holmes
Journal:  Int J Cogn Ther       Date:  2011-06

Review 6.  Elevated reward-related neural activation as a unique biological marker of bipolar disorder: assessment and treatment implications.

Authors:  Robin Nusslock; Christina B Young; Katherine S F Damme
Journal:  Behav Res Ther       Date:  2014-09-01

7.  Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression.

Authors:  Janusz K Rybakowski; Jules Angst; Dominika Dudek; Tomasz Pawlowski; Dorota Lojko; Marcin Siwek; Andrzej Kiejna
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-06-26       Impact factor: 5.270

8.  Hypomanic Experience in Young Adults Confers Vulnerability to Intrusive Imagery After Experimental Trauma: Relevance for Bipolar Disorder.

Authors:  Aiysha Malik; Guy M Goodwin; Laura Hoppitt; Emily A Holmes
Journal:  Clin Psychol Sci       Date:  2014-11

9.  Involuntary memories after a positive film are dampened by a visuospatial task: unhelpful in depression but helpful in mania?

Authors:  Charlotte Davies; Aiysha Malik; Arnaud Pictet; Simon E Blackwell; Emily A Holmes
Journal:  Clin Psychol Psychother       Date:  2012-05-09

10.  Screening for Bipolar Disorder Symptoms in Depressed Primary Care Attenders: Comparison between Mood Disorder Questionnaire and Hypomania Checklist (HCL-32).

Authors:  Anna Sasdelli; Loredana Lia; C Claudia Luciano; Claudia Nespeca; Domenico Berardi; Marco Menchetti
Journal:  Psychiatry J       Date:  2013-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.